Rising Prevalence Of Infectious Diseases To Drive Market Growth: A Key Factor Shaping the Future of the Viral Inactivation Market in 2025

Which drivers are expected to have the greatest impact on the over the viral inactivation market's growth?
The escalation in various infectious disease occurrences is anticipated to bolster the growth of the viral inactivation market. Infectious diseases are conditions transmittable from one person to another, through contaminated food and beverages, or pathogens like viruses, bacteria, fungi, and parasites. Viral inactivation, extensively used in human disease-control mechanisms, employs physical and chemical sterilisers to halt the dissemination of infectious viral diseases, hence boosting the expansion of the viral inactivation market. For example, the Centers for Disease Control and Prevention noted in March 2024 that the US saw an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, an expansion of 1,295 cases. The incident rate grew from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Consequently, the escalating prevalence of various infectious diseases is fuelling the growth of the viral inactivation market.

Get Your Viral Inactivation Market Report Here:
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

What is the future CAGR of the viral inactivation market, and how will it impact industry expansion?
In recent times, the viral inactivation market has witnessed notable growth. The market size, which is presently at $5.01 billion in 2024 is expected to climb up to $5.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. This increase during the historical period can be credited to factors such as a surge in global air traffic, advancement in navigation capacities, the extension of commercial aviation, savings in airline costs, improvements in flight security, and decrease in the workload of pilots.

The market size for viral inactivation is predicted to experience a significant surge in the upcoming years. It's projected to reach "$8.28 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 10.9%. This projected growth within the forecast period is linked to the advancement in autonomous flights, the creation of next generation aircraft designs, initiatives towards sustainable aviation, urban air mobility (uam), and a rise in the demand for aircraft. The forecast period will also witness major trends such as the incorporation of cutting-edge avionics, the application of artificial intelligence, innovations in the human-machine interface (hmi), refitting of current aircrafts, and the integration of the global navigation satellite system (gnss).

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

What are the most significant trends transforming the viral inactivation market today?
Advancements in technology being adopted by companies in the viral inactivation market is a significant trend gaining traction. To solidify their market position, companies are incorporating these advanced technological processes. For example, WuXi Advanced Therapies, fully owned by WuXi AppTec, a biopharmaceutical firm based in China, in March 2022 launched the Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This avant-garde technology has paved the way for new therapy approvals by executing all assay formulation, biosafety, viral clearance, product release and testing simultaneously in-house. It's an original innovative approach to produce adeno-associated virus (AAV) at a GMP grade without requiring transfection.

Which key market segments comprise the viral inactivation market and drive its revenue growth?
The viral inactivation market covered in this report is segmented -

1) By Product: Kits And Reagents, Systems, Services
2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

Subsegments:
1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes
2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems
3) By Services: Viral Testing Services, Validation Services, Consulting Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

What regions are at the forefront of viral inactivation market expansion?
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the viral inactivation market?
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

What Is Covered In The Viral Inactivation Global Market Report?

• Market Size Forecast: Examine the viral inactivation market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the viral inactivation market for a structured understanding.
• Key Players Overview: Analyze major players in the viral inactivation market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the viral inactivation market.
• Segment Contributions: Evaluate how different segments drive overall growth in the viral inactivation market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the viral inactivation market.
• Industry Challenges: Identify potential risks and obstacles affecting the viral inactivation market.
• Competitive Landscape: Review strategic developments in the viral inactivation market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.